Goodwin, MoFo, Slaughters guide $478 mln bio-pharma acquisition
U.S. law firm Morrison Foerster has advised Japan’s Kyowa Kirin on its $477.6 million acquisition of British biopharmaceutical company Orchard Therapeutics, which was represented by Goodwin Procter. Slaughter & May was Orchard’s UK legal advisor.
Wilson, Goodwin on Cheche Group’s de-SPAC merger, achieving NASDAQ listing
Chinese auto insurance technology platform Cheche Group has recently completed its merger with the Special Purpose Acquisition Company (SPAC) Prime Impact Acquisition I, formerly listed on the New York Stock Exchange. As of Sep.18, the merged entity has become a publicly traded company listed on NASDAQ.
Goodwin, Nelson Mullins advise on Crown LNG’s $685 mln SPAC deal
U.S. law firm Goodwin Procter has advised Catcha Investment, a publicly traded special purpose acquisition company, on its merger agreement with Crown LNG Holdings, which develops liquefied natural gas terminals to operate in harsh weather conditions.